{"organizations": [], "uuid": "eb6d7015bb09ad23f04dec86af98a3f671e26f61", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/9", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/19/business-wire-the-medicines-company-to-announce-first-quarter-2018-financial-results-on-april-25.html", "country": "US", "domain_rank": 767, "title": "The Medicines Company to Announce First- Financial Results on April 25", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.555, "site_type": "news", "published": "2018-04-19T15:00:00.000+03:00", "replies_count": 0, "uuid": "eb6d7015bb09ad23f04dec86af98a3f671e26f61"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/19/business-wire-the-medicines-company-to-announce-first-quarter-2018-financial-results-on-april-25.html", "ord_in_thread": 0, "title": "The Medicines Company to Announce First- Financial Results on April 25", "locations": [], "entities": {"persons": [], "locations": [{"name": "n.j.", "sentiment": "none"}, {"name": "parsippany", "sentiment": "none"}, {"name": "canada", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "medicines company", "sentiment": "negative"}, {"name": "company", "sentiment": "none"}, {"name": "medicines company the medicines company", "sentiment": "none"}, {"name": "eastern time", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Wednesday, April 25, 2018, at 8:30 a.m., Eastern Time, to discuss first-quarter 2018 financial results and operational developments.\nThe conference call may be accessed by telephone as follows:\nU.S./Canada: (877) 359-9508 International: (224) 357-2393 Conference ID: 5683598 A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:\nU.S./Canada: (855) 859-2056 International: (404) 537-3406 Conference ID: 5683598 A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website. An archived webcast will be available after the call concludes.\nAbout The Medicines Company\nThe Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s goal is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians, and providers in cardiovascular care. The Company is headquartered in Parsippany, New Jersey.\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180419005332/en/\nThe Medicines Company\nInvestor Relations\nKrishna Gorti, M.D., 973-290-6122\nVice President, Investor Relations\nkrishna.gorti@themedco.com\nSource: The Medicines Company", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.themedicinescompany.com%2Finvestors%2Fevents&esheet=51791493&newsitemid=20180419005332&lan=en-US&anchor=Investors+section+of+The+Medicines+Company&index=1&md5=0fba8567d094b0fa18becd632274c767", "https://www.businesswire.com/news/home/20180419005332/en/"], "published": "2018-04-19T15:00:00.000+03:00", "crawled": "2018-04-19T18:14:26.005+03:00", "highlightTitle": ""}